These are additional notices applicable to this website.
The Ohio State University
A live recombinant vesicular stomatitis virus (VSV)-vector vaccine composition for human norovirus.
A novel method to increase vaccine effectiveness for TB
Silvestrol promotes the prevention and treatment of various cancers as an immune adjuvant.
©2016 The Ohio State University
Technology Commercialization Office
1524 North High Street | Columbus, Ohio 43201
Contact: email@example.com | 614.292.1315
Webmaster | Page maintained by TCO
1524 N. High Street
Columbus, Ohio 43201